<DOC>
	<DOCNO>NCT01776619</DOCNO>
	<brief_summary>Safety , tolerability PK repeat dos PF-06305591 evaluate young healthy volunteer toghether food effect relative bioavailability solid formulation single dose .</brief_summary>
	<brief_title>Safety Tolerability Study Multiple Doses PF-06305591</brief_title>
	<detailed_description />
	<criteria>Healthy male female subject non childbearing potential , age 21 55 year , inclusive . Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12 lead ECG clinical laboratory test Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . Any condition possibly affect drug absorption ( eg , gastrectomy ) .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>PK</keyword>
</DOC>